Angel Medical’s Fischell wins Young Entrepreneur Of The Year® Award

413

SHREWSBURY – Angel Medical Systems, Inc., a privately held medical device company developing implant­able technologies for heart attack detection and patient alerting, announced today that its CEO, Dr. David R. Fischell, was selected as the Ernst & Young Entrepreneur of the Year 2013 NJ Regional Award winner in Biotech­nology and Medical Technology.

Dr. David R. Fischell
Dr. David R. Fischell

Finalists were selected by a panel of independent judges based on success in areas such as innovation and financial performance and the entrepreneurs’ personal commitment to their businesses and communities. Fischell was announced as the winner at a special gala event held Thursday, June 13 in New Brunswick.
Fischell holds 114 patents and is a serial entrepreneur who has founded nine biomedical device companies in the past 15 years. He was also the primary designer of the BX Velocity and Cypher coronary stents for Cordis, a Johnson & Johnson Co.
More than 1.3 million people have a heart attack every year, and half of those individuals have no physical symptoms, atypical symptoms, or delay seeking care for three hours or more, resulting in significant heart damage or death.
The AngelMed Guardian® System heart monitor is designed to track significant changes in the heart’s electrical signal, identify the signature of acute thrombotic occlusions, and then alert the patient to seek immediate medical attention.
The Guardian System has CE Mark approval in Europe, and is being actively implanted in Germany. The system is also commercially available in Brazil, and is in a pivotal clinical study in 100 medical centers in the United States.
“I am excited to be recognized by Ernst & Young, and am especially thankful to the groups of dedicated people who have helped take my inventions from concept into medical devices that can really help people. Special thanks to the team at Angel Medical Systems who have worked so hard to guide the AngelMed Guardian System to completion of enrollment of its pivotal FDA clinical study this past week,” said Fischell.
Ernst & Young Entre­preneur Of The Year is a most prestigious business award for entrepreneurs. The unique award makes a difference through the way it encourages entrepreneurial activity among those with potential, and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 140 cities in more than 50 countries.
For more information, contact Marcia Makoviecki, director of Communications at 732-542-5551, or visit www.angel-med.com.